Author

D. W. Cescon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1

Frequent Co-Authors

A. A. N. Rose· 1 shared A. J. Elia· 1 shared A. Spreafico· 1 shared B. Haibe-Kains· 1 shared B. Wu· 1 shared C. di Ciano-Oliveira· 1 shared C. Zhang· 1 shared D. Gendoo· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. N. Rose

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification

C. Zhang, B. Wu, Y. F. Wu, C. di Ciano-Oliveira, I. Soria-Bretones, N.-A. Pham, A. J. Elia, R. Chari, W. L. Lam, M. R. Bray, T. W. Mak, M.-S. Tsao, D. W. Cescon, K. L. Thu

This study identifies KIFC1 as a therapeutic vulnerability in lung cancers with centrosome amplification by showing its role in mitigating mitotic stress.

bioRxiv · Jan 9, 2024Cancer Biology

The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers

S. Kazandjian, E. Rousselle, M. Dankner, D. W. Cescon, A. Spreafico, K. Ma, P. Kavan, G. Batist, A. A. N. Rose

This paper analyzes the clinical, genomic, and transcriptomic features of BRAF mutant cancers across multiple tumor types and identifies demographic and molecular differences between BRAF mutation classes.

bioRxiv · Sep 15, 2023Cancer Biology

Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies

J. E. van Leeuwen, W. Ba-Alawi, E. Branchard, J. Longo, J. Silvester, D. W. Cescon, B. Haibe-Kains, L. Penn, D. Gendoo

bioRxiv · Sep 7, 2020 · PreprintCancer Biology